National Institutes of Health has invested $10.1 million in supplemental funding to bolster the research of 82 grantees to explore the effects of sex in preclinical and clinical studies.
This investment encourages researchers to study females and males, and is a catalyst for considering sex as a fundamental variable in research. The current overreliance on male subjects in preclinical research can obscure key findings related to sex that could guide later human studies. This progressive approach will result in greater awareness of the need to study both sexes, demonstrate how research can incorporate sex, and reinforce the value of taking it into account as these studies yield results.
The Women's Health Research Institute has been actively supporting more sex equity in research not only at the human level but also in critical preclinical animal and cell research. To read more about the NIH announcement, click HERE.